|
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida |
Cure4Cam Childhood Cancer Foundation |
|
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
|
HA-1 TCR T-cell Immunotherapy for Acute Leukemia |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation, Marshall County Childhood Cancer Awareness Corporation |
|
HA-1 TCR T-cell Immunotherapy for Acute Leukemia |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation, Marshall County Childhood Cancer Awareness Corporation |
|
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
|
Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia
|
Massachusetts General Hospital |
Cure4Cam Childhood Cancer Foundation |
|
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University |
Flashes of Hope |
|
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |
|
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado |
Northwestern Mutual Foundation |
|
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute |
I Care I Cure |
